Other miR-139 targets that are described in leukemia and some other types of cancer are BTG3 [46], the RNA-binding protein ELAVL1 [45,65,72], Tetraspanin-3 (TSPAN3), MAX Network Transcriptional Repressor (MNT) [48], 15-Hydroxyprostaglandin Dehydrogenase (HPGD) and Protein Tyrosine phosphatase Receptor Type-T (PTPRT) [38]. The gene discussed is HPGD; the disease is cancer.